CICAD Sessions

 
Document No.DescriptionSize

Photo Gallery

Note

Convocation

Updated on Oct 6 2017 10:55AM

42 Kb.
INF.1

Information Bulletin

Updated on Oct 16 2017 5:02PM

461 Kb.
2324

Draft Agenda Rev.1

Updated on Nov 21 2017 3:26PM

260 Kb.
2325

Draft Schedule of Activities Rev.2

Updated on Dec 12 2017 4:30PM

135 Kb.
2327

The Government of Panama withdraws its candidacy for CICAD Vice-Chair

Updated on Oct 23 2017 5:53PM

806 Kb.
2328

MEM proposed Evaluation Instrument

Updated on Nov 22 2017 12:53PM

1,703 Kb.
2329

FRAMEWORK TO EXPAND INTEGRATED, SUSTAINABLE ALTERNATIVE DEVELOPMENT IN THE AMERICAS

Updated on Dec 14 2017 11:12AM

465 Kb.
2330

Colombia Candidacy Vice-Chair of the Group of Experts for the Control of Money Laundering (GELAVEX)

Updated on Dec 1 2017 12:00PM

251 Kb.
2331

Final Report CICAD Expert Group on Demand Reduction

Updated on Dec 1 2017 12:02PM

1,676 Kb.
2332

Final Report - XLIV Meeting of the Group of Experts for the Control of Money Laundering

Updated on Dec 13 2017 10:20AM

625 Kb.
2334

An Overview of the Government of Canada’s Approach to Legalize, Regulate and Restrict Access to Cannabis
Krista Apse,
Director,
External Relations, Cannabis Legalization and Regulation Branch,
Health Canada

Updated on Dec 14 2017 1:05PM

1,908 Kb.
2336

Candidacy of the Republic of Argentina to the Vice Chair of CICAD

Updated on Dec 5 2017 11:26AM

384 Kb.
2337

Candidacy of the Republic of Ecuador to the Vice Chair of CICAD

Updated on Dec 5 2017 4:01PM

324 Kb.
2338

Reform to the General Health Law on Cannabis
Alberto Miguel Guzmán,
Executive Director, for Narcotics Regulation,
Federal Commission for the Protection against Sanitary Risk (COFEPRIS),
Mexico

Updated on Dec 14 2017 1:03PM

2,155 Kb.
2339

Institutional framework, knowledge management and development of national and territorial capacities for the prevention and attention of the consumption of psychoactive substances from the public health approach

A experience of Colombia

Ana María Peñuela Poveda
Ministerio de Salud y Protección Social
República de Colombia

Updated on Dec 14 2017 3:11PM

1,781 Kb.
2340

Access to Opioids and Controlled Substances
Rossen Popov
Deputy Secretary INCB

Updated on Dec 14 2017 11:25AM

2,529 Kb.
2341

Report of the Inter-Governmental Working Group (IWG) of the Multilateral Evaluation Mechanism (MEM)

Updated on Dec 12 2017 6:11PM

275 Kb.
2342

Final Report - Expert Group on Comprehensive and Sustainable Alternative Development (GEDAIS)

Updated on Dec 12 2017 10:45AM

505 Kb.
2343

New trends and emerging challenges in the international control of chemical precursors, synthetic drugs and new psychoactive substances
Verónica España Carbente,
Director of Information and analysis, Use and Traffic of Chemical Substances, National Center for the Planning, Analysis, and Information for Combating Crime (CENAPI) , Office of the Attorney General (PGR),
Mexico

Updated on Dec 13 2017 3:31PM

2,136 Kb.
2344

Challenges in the control of synthetic drugs
Jose de Gracia,
Assistant Director for Criminal Networks,
INTERPOL

Updated on Dec 13 2017 10:15AM

707 Kb.
2345

A Comprehensive Approach to Drug Demand Reduction – A Caribbean Perspective
MS. ESTHER BEST
MANAGER
NATIONAL DRUG COUNCIL OF TRINIDAD AND TOBAGO AND
CHAIR OF THE REGIONAL ADVISORY COUNCIL OF PROCCER

Updated on Dec 14 2017 3:04PM

1,014 Kb.
2346

Scientific evidence and information for the development of drug policy
Oscar Aarón Santiago Quintos,
General Director of Analysis, Criminal
Investigation Agency, Office of the Attorney General (PGR),
Mexico

Updated on Dec 14 2017 11:34AM

2,572 Kb.
2347

New trends and emerging challenges in the international control of chemical precursors, synthetic drugs and new psychoactive substances
Joseph Schleigh, Acting Section Chief,
Synthetics Drugs and Chemicals Section,
Drug Enforcement Administration (DEA),
United States of America

Updated on Dec 13 2017 10:16AM

1,360 Kb.
2348

Multilateral Evaluation Mechanism (MEM) Activities – 7th Round
Sofia I. Kosmas
Chief of the MEM Unit

Updated on Dec 13 2017 10:03AM

680 Kb.
2349

REGULATION OF CANNABIS IN URUGUAY
Diego Martín Olivera Couto,
Secretary General,
National Drug Secretariat,
Presidency of the Republic, Uruguay

Updated on Dec 14 2017 1:02PM

1,642 Kb.
2350

ACCESS TO CONTROLLED SUBSTANCES FOR MEDICAL PURPOSES
Alberto Miguel Guzmán,
Executive Director, Narcotics Regulation, Federal
Commission for the Protection against Sanitary Risk (COFEPRIS),
Mexico

Updated on Dec 14 2017 11:41AM

4,158 Kb.
2351

Generation and Strengthening of Human Talent in National Health Systems for Drug Demand Reduction
Dr. Silvia Morales Chainé
School of Psychology, UNAM

Updated on Dec 14 2017 3:13PM

3,226 Kb.
2352

XVIII MEETING OF GROUP OF EXPERTS ON DEMAND REDUCTION

Updated on Dec 13 2017 4:52PM

1,603 Kb.
2353

Integral Prevention Programs to Address the Drug Problem
June S. Sivilli
Chief, Public Health & Public Safety Division
Office of National Drug Control Policy
Executive Office of the President United States of America

Updated on Dec 14 2017 3:20PM

2,708 Kb.
2354

Safe and Balanced Access to Opioids for Medical Uses: Guidance from Disease Control Priorities 3rd Ed., the Lancet Commission on Palliative Care

Eric Krakauer, MD, PhD
Director of Global Programs, Center for Palliative Care,
Assoc. Prof. of Medicine and of Global Health & Social Medicine, Harvard Medical School.
Attending Physician, Palliative Care Division, Massachusetts General Hospital.
Consultant in Palliative Care, WHO.

Updated on Dec 14 2017 11:40AM

1,314 Kb.